A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesDavid C. Jackson, Lorena E. Brown, Yuk Fai Lau et al.|Proceedings of the National Academy of Sciences|2004Cited by 235
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A. Amarilla, Alexander A. Khromykh, Darwin J. Da Costa Guevara et al.|Nature Communications|2021Cited by 177
Phase I Trial of a CD8<sup>+</sup>T-Cell Peptide Epitope-Based Vaccine for Infectious MononucleosisSuzanne Elliott, Mandvi Bharadwaj, Andreas Suhrbier et al.|Journal of Virology|2007Cited by 148
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 InteractionScott E. Guimond, Jeremy E. Turnbull, Courtney J. Mycroft‐West et al.|ACS Central Science|2022Cited by 112
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S. Morgan, Jody Hobson‐Peters, Kexin Yan et al.|Viruses|2022Cited by 21